Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL StudyPhilip J. Johnson, Ann‐Lii Cheng, Joong‐Won Park et al.|Journal of Clinical Oncology|2013Cited by 775
Knockdown of metadherin inhibits cell proliferation and migration in colorectal cancerJianwang Li, Ligong Lu|Oncology Reports|2018Cited by 21
3D‐Epigenomic Regulation of Gene Transcription in Hepatocellular CarcinomaYuliang Feng, Ligong Lu|Advanced Genetics|2022Cited by 5